Filing Details
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 23, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:IART
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Files Quarterly Report for Q0
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 23, 2026.
At publication ·
What changed
INTEGRA LIFESCIENCES HOLDINGS CORP (NASDAQ:IART) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Integra LifeSciences Holdings Corp filed its Q0 quarterly report (Form 10-Q) with the SEC on October 23, 2026.
- The company's stock trades at $11.91 with a market capitalization of $1.1 billion.
- The 10-Q filing contains unaudited financial statements, management commentary, and updates on emerging trends and risk factors.
Market Context
INTEGRA LIFESCIENCES HOLDINGS CORP's stock currently trades at $11.91 with a market capitalization of $1.1B.
The 10-Q provides INTEGRA LIFESCIENCES HOLDINGS CORP's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for INTEGRA LIFESCIENCES HOLDINGS CORP are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IART Stock Page
Frequently Asked Questions
Where can I read IART's SEC filings?
Browse all filings on our IART SEC filings page.
What types of SEC filings does INTEGRA LIFESCIENCES HOLDINGS CORP file?
Public companies like INTEGRA LIFESCIENCES HOLDINGS CORP file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
